Concert recording 2022-10-12

[Track 1]. Sonata for four trombones / Georg Daniel Speer -- [Track 2]. Scarborough fair / traditional ; arr. Bill Reichenbach -- [Track 3]. Quartet for trombones / Leslie Bassett -- [Track 4]. You made me love you / James Monaco ; arr. Bill Holcombe -- [Track 5]. Fanfare for 8 trombones / Michael P. Terry -- [Track 6]. Andante cantabile from Symphony no. 5, Mtv. II / Pyort IIlich Tchaikovsky ; arr. Nolan Miller -- [Track 7]. Rising tide / Jack Wilds

Concert recording 2022-10-12

[Track 1]. Sonata for four trombones / Georg Daniel Speer -- [Track 2]. Scarborough fair / traditional ; arr. Bill Reichenbach -- [Track 3]. Quartet for trombones / Leslie Bassett -- [Track 4]. You made me love you / James Monaco ; arr. Bill Holcombe -- [Track 5]. Fanfare for 8 trombones / Michael P. Terry -- [Track 6]. Andante cantabile from Symphony no. 5, Mtv. II / Pyort IIlich Tchaikovsky ; arr. Nolan Miller -- [Track 7]. Rising tide / Jack Wilds

Concert recording 2022-11-08

[Track 1]. Beau soir / Claude Debussy -- The lass from the Low Countree / John Jacob Niles – [Track 2]. Into the night / Clara Edwards -- [Track 3]. An Silvia / Franz Schubert -- [Track 4]. Se tu m’ami, se sospiri / Alessandro Parisotti -- [Track 5]. Erlafsee / Franz Schubert -- [Track 6]. Vittoria, mio core / Giacomo Carissimi -- [Track 7]. Aufenthalt / Franz Schubert -- [Track 8]. Amarilli, mia bella / Giulio Caccini -- [Track 9]. There’s a Fine, Fine Line, from Avenue Q / Robert Lopez and Jeff Marx -- [Track 10]. Go, lovely rose / Roger Quilter -- [Track 11]. Vagabond / Ralph Vaughan Williams -- [Track 12]. Sebben, crudele / Antonio Caldara -- [Track 13]. Love’s philosophy / Roger Quilter (1877–1953) -- [Track 14]. Perla gloria / Giovanni Bononcini -- [Track 15]. Money, O! / Michael Head -- [Track 16]. Lasciate mi morire / Claudio Monteverdi -- Across the western ocean / Arr. Celius Dougherty -- [Track 17]. Perduta ho la Speranza / Stefano Donaudy -- [Track 18]. Lonley House from Street Scene / Kurt Weill -- [Track 19]. Preghiera / Paolo Tosti -- [Track 20]. Allerseelen / Richard Strauss -- [Track 21]. Im wunderschönen Monat Mai / Robert Schumann -- [Track 22]. Una furtiva lagrima from L’elisir d’amore / Gaetano Donizetti -- [Track 23]. V’adoro, pupille, from Giulio Cesare / George Handel -- [Track 24]. Sympathy / Florence Price -- [Track 25]. The German U-boat captain / Gene Scheer -- [Track 26]. Eri tu che macchiavi, from Un Ballo in Maschera / Giuseppe Verdi

Concert recording 2022-11-08

[Track 1]. Beau soir / Claude Debussy -- The lass from the Low Countree / John Jacob Niles – [Track 2]. Into the night / Clara Edwards -- [Track 3]. An Silvia / Franz Schubert -- [Track 4]. Se tu m’ami, se sospiri / Alessandro Parisotti -- [Track 5]. Erlafsee / Franz Schubert -- [Track 6]. Vittoria, mio core / Giacomo Carissimi -- [Track 7]. Aufenthalt / Franz Schubert -- [Track 8]. Amarilli, mia bella / Giulio Caccini -- [Track 9]. There’s a Fine, Fine Line, from Avenue Q / Robert Lopez and Jeff Marx -- [Track 10]. Go, lovely rose / Roger Quilter -- [Track 11]. Vagabond / Ralph Vaughan Williams -- [Track 12]. Sebben, crudele / Antonio Caldara -- [Track 13]. Love’s philosophy / Roger Quilter (1877–1953) -- [Track 14]. Perla gloria / Giovanni Bononcini -- [Track 15]. Money, O! / Michael Head -- [Track 16]. Lasciate mi morire / Claudio Monteverdi -- Across the western ocean / Arr. Celius Dougherty -- [Track 17]. Perduta ho la Speranza / Stefano Donaudy -- [Track 18]. Lonley House from Street Scene / Kurt Weill -- [Track 19]. Preghiera / Paolo Tosti -- [Track 20]. Allerseelen / Richard Strauss -- [Track 21]. Im wunderschönen Monat Mai / Robert Schumann -- [Track 22]. Una furtiva lagrima from L’elisir d’amore / Gaetano Donizetti -- [Track 23]. V’adoro, pupille, from Giulio Cesare / George Handel -- [Track 24]. Sympathy / Florence Price -- [Track 25]. The German U-boat captain / Gene Scheer -- [Track 26]. Eri tu che macchiavi, from Un Ballo in Maschera / Giuseppe Verdi

Researching COVID to Enhance Recovery (RECOVER) Adult Study Protocol: Rationale, Objectives, and Design

IMPORTANCE: SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID. The characteristics, prevalence, trajectory and mechanisms of PASC are ill-defined. The objectives of the Researching COVID to Enhance Recovery (RECOVER) Multi-site Observational Study of PASC in Adults (RECOVER-Adult) are to: (1) characterize PASC prevalence; (2) characterize the symptoms, organ dysfunction, natural history, and distinct phenotypes of PASC; (3) identify demographic, social and clinical risk factors for PASC onset and recovery; and (4) define the biological mechanisms underlying PASC pathogenesis. METHODS: RECOVER-Adult is a combined prospective/retrospective cohort currently planned to enroll 14,880 adults aged ≥18 years. Eligible participants either must meet WHO criteria for suspected, probable, or confirmed infection; or must have evidence of no prior infection. Recruitment occurs at 86 sites in 33 U.S. states, Washington, DC and Puerto Rico, via facility- and community-based outreach. Participants complete quarterly questionnaires about symptoms, social determinants, vaccination status, and interim SARS-CoV-2 infections. In addition, participants contribute biospecimens and undergo physical and laboratory examinations at approximately 0, 90 and 180 days from infection or negative test date, and yearly thereafter. Some participants undergo additional testing based on specific criteria or random sampling. Patient representatives provide input on all study processes. The primary study outcome is onset of PASC, measured by signs and symptoms. A paradigm for identifying PASC cases will be defined and updated using supervised and unsupervised learning approaches with cross-validation. Logistic regression and proportional hazards regression will be conducted to investigate associations between risk factors, onset, and resolution of PASC symptoms. DISCUSSION: RECOVER-Adult is the first national, prospective, longitudinal cohort of PASC among US adults. Results of this study are intended to inform public health, spur clinical trials, and expand treatment options

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.

Funder: laura and john arnold foundationBACKGROUND: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). METHODS: In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung-Knapp-Sidik-Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. RESULTS: A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. CONCLUSIONS: Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care

Search for new particles in events with energetic jets and large missing transverse momentum in proton-proton collisions at root s=13 TeV

A search is presented for new particles produced at the LHC in proton-proton collisions at root s = 13 TeV, using events with energetic jets and large missing transverse momentum. The analysis is based on a data sample corresponding to an integrated luminosity of 101 fb(-1), collected in 2017-2018 with the CMS detector. Machine learning techniques are used to define separate categories for events with narrow jets from initial-state radiation and events with large-radius jets consistent with a hadronic decay of a W or Z boson. A statistical combination is made with an earlier search based on a data sample of 36 fb(-1), collected in 2016. No significant excess of events is observed with respect to the standard model background expectation determined from control samples in data. The results are interpreted in terms of limits on the branching fraction of an invisible decay of the Higgs boson, as well as constraints on simplified models of dark matter, on first-generation scalar leptoquarks decaying to quarks and neutrinos, and on models with large extra dimensions. Several of the new limits, specifically for spin-1 dark matter mediators, pseudoscalar mediators, colored mediators, and leptoquarks, are the most restrictive to date.Peer reviewe

Probing effective field theory operators in the associated production of top quarks with a Z boson in multilepton final states at root s=13 TeV

Peer reviewe

On the assessment of landmark salience for human navigation

In this paper, we propose a conceptual framework for assessing the salience of landmarks for navigation. Landmark salience is derived as a result of the observer’s point of view, both physical and cognitive, the surrounding environment, and the objects contained therein. This is in contrast to the currently held view that salience is an inherent property of some spatial feature. Salience, in our approach, is expressed as a three-valued Saliency Vector. The components that determine this vector are Perceptual Salience, which defines the exogenous (or passive) potential of an object or region for acquisition of visual attention, Cognitive Salience, which is an endogenous (or active) mode of orienting attention, triggered by informative cues providing advance information about the target location, and Contextual Salience, which is tightly coupled to modality and task to be performed. This separation between voluntary and involuntary direction of visual attention in dependence of the context allows defining a framework that accounts for the interaction between observer, environment, and landmark. We identify the low-level factors that contribute to each type of salience and suggest a probabilistic approach for their integration. Finally, we discuss the implications, consider restrictions, and explore the scope of the framework

Measurement of the Higgs boson production rate in association with top quarks in final states with electrons, muons, and hadronically decaying tau leptons at s√=13TeV

The rate for Higgs (H) bosons production in association with either one (tH) or two (tt¯H) top quarks is measured in final states containing multiple electrons, muons, or tau leptons decaying to hadrons and a neutrino, using proton–proton collisions recorded at a center-of-mass energy of 13TeV by the CMS experiment. The analyzed data correspond to an integrated luminosity of 137fb−1. The analysis is aimed at events that contain H→WW, H→ττ, or H→ZZ decays and each of the top quark(s) decays either to lepton+jets or all-jet channels. Sensitivity to signal is maximized by including ten signatures in the analysis, depending on the lepton multiplicity. The separation among tH, tt¯H, and the backgrounds is enhanced through machine-learning techniques and matrix-element methods. The measured production rates for the tt¯H and tH signals correspond to 0.92±0.19(stat)+0.17−0.13(syst) and 5.7±2.7(stat)±3.0(syst) of their respective standard model (SM) expectations. The corresponding observed (expected) significance amounts to 4.7 (5.2) standard deviations for tt¯H, and to 1.4 (0.3) for tH production. Assuming that the Higgs boson coupling to the tau lepton is equal in strength to its expectation in the SM, the coupling yt of the Higgs boson to the top quark divided by its SM expectation, κt=yt/ySMt, is constrained to be within −0.9<κt<−0.7 or 0.7<κt<1.1, at 95% confidence level. This result is the most sensitive measurement of the tt¯H production rate to date.SCOAP